{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:56:46Z","timestamp":1790618206394,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11302-026-10190-2","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:06:24Z","timestamp":1790615184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["P2X7 receptor gene polymorphisms in atherosclerosis patients classified based on angiographic stenosis grading"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1236-2432","authenticated-orcid":false,"given":"S\u00fcleyman","family":"Ince","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0999-2774","authenticated-orcid":false,"given":"Ahu","family":"Soyocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0475-7612","authenticated-orcid":false,"given":"Funda Seher","family":"\u00d6zalp Ate\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7292-7516","authenticated-orcid":false,"given":"Emrah","family":"Ermi\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"10190_CR1","first-page":"3868","volume":"13","author":"KS Allemailem","year":"2021","unstructured":"Allemailem KS, Almatroudi A, Alrumaihi F, Almansour NM, Aldakheel FM, Rather RA, Rah B (2021) Single nucleotide polymorphisms (SNPs) in prostate cancer: its implications in diagnostics and therapeutics. Am J Transl Res 13:3868","journal-title":"Am J Transl Res"},{"key":"10190_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4238\/2013.January.24.8","volume":"12","author":"G Bahari","year":"2013","unstructured":"Bahari G, Hashemi M, Taheri M, Naderi M, Moazeni-Roodi A, Kouhpayeh HR, Eskandari-Nasab E (2013) Association of P 2 X 7 gene polymorphisms with susceptibility to pulmonary tuberculosis in Zahedan: Southeast Iran. Genet Mol Res 12:160\u2013166","journal-title":"Genet Mol Res"},{"key":"10190_CR3","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1007\/s10067-021-05645-3","volume":"40","author":"G Bahari","year":"2021","unstructured":"Bahari G, Tabasi F, Hashemi M, Zakeri Z, Taheri M (2021) Association of P2X7 receptor genetic polymorphisms and expression with rheumatoid arthritis susceptibility in a sample of the Iranian population: a case-control study. Clin Rheumatol 40:3115\u20133126","journal-title":"Clin Rheumatol"},{"key":"10190_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2174\/138920208783884856","volume":"9","author":"E Biros","year":"2008","unstructured":"Biros E, Karan M, Golledge J (2008) Genetic variation and atherosclerosis. Curr Genomics 9:29\u201342","journal-title":"Curr Genomics"},{"key":"10190_CR5","first-page":"1","volume-title":"Dual antiplatelet therapy for coronary and peripheral arterial disease","author":"SJ Brener","year":"2021","unstructured":"Brener SJ (2021) Platelets and arterial disease\u2014initiation, progression, and destabilization of atherosclerotic vascular disease. Dual antiplatelet therapy for coronary and peripheral arterial disease. Elsevier, pp 1\u201313"},{"key":"10190_CR6","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cca.2018.01.032","volume":"479","author":"Z Chen","year":"2018","unstructured":"Chen Z, He L, Li L, Chen L (2018) The P2X7 purinergic receptor: an emerging therapeutic target in cardiovascular diseases. Clin Chim Acta 479:196\u2013207","journal-title":"Clin Chim Acta"},{"key":"10190_CR7","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/eurjpc\/zwae281","volume":"32","author":"B Chong","year":"2025","unstructured":"Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Goh R, Kueh MTW, Li H, Chin YH, Kong G, Anand VV (2025) Global burden of cardiovascular diseases: projections from 2025 to 2050. Eur J Prev Cardiol 32:1001\u20131015","journal-title":"Eur J Prev Cardiol"},{"key":"10190_CR8","doi-asserted-by":"publisher","first-page":"E84","DOI":"10.5888\/pcd19.220347","volume":"19","author":"F Coronado","year":"2022","unstructured":"Coronado F, Melvin SC, Bell RA, Zhao G (2022) Global responses to prevent, manage, and control cardiovascular diseases. Prev Chronic Dis 19:E84. https:\/\/doi.org\/10.5888\/pcd19.220347","journal-title":"Prev Chronic Dis"},{"key":"10190_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jnutbio.2009.10.012","volume":"21","author":"V Costa","year":"2010","unstructured":"Costa V, Casamassimi A, Ciccodicola A (2010) Nutritional genomics era: opportunities toward a genome-tailored nutritional regimen. J Nutr Biochem 21:457\u2013467","journal-title":"J Nutr Biochem"},{"key":"10190_CR10","doi-asserted-by":"publisher","first-page":"5673","DOI":"10.3390\/molecules28155673","volume":"28","author":"SA Dabravolski","year":"2023","unstructured":"Dabravolski SA, Sukhorukov VN, Melnichenko AA, Khotina VA, Orekhov AN (2023) Potential application of the plant-derived essential oils for atherosclerosis treatment: molecular mechanisms and therapeutic potential. Molecules 28:5673","journal-title":"Molecules"},{"key":"10190_CR11","doi-asserted-by":"publisher","first-page":"110635","DOI":"10.18632\/oncotarget.22372","volume":"8","author":"NA Deng","year":"2017","unstructured":"Deng NA, Zhou H, Fan H, Yuan Y (2017) Single nucleotide polymorphisms and cancer susceptibility. Oncotarget 8:110635","journal-title":"Oncotarget"},{"key":"10190_CR12","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.12659\/MSM.895763","volume":"22","author":"S Duan","year":"2016","unstructured":"Duan S, Yu J, Han Z, Cheng Z, Liang P (2016) Association between P2RX7 gene and hepatocellular carcinoma susceptibility: a case-control study in a Chinese Han population. Med Sci Monit 22:1916","journal-title":"Med Sci Monit"},{"key":"10190_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11302-009-9136-4","volume":"5","author":"SJ Fuller","year":"2009","unstructured":"Fuller SJ, Stokes L, Skarratt KK, Gu BJ, Wiley JS (2009) Genetics of the P2X7 receptor and human disease. Purinergic Signal 5:257\u2013262","journal-title":"Purinergic Signal"},{"key":"10190_CR14","doi-asserted-by":"publisher","first-page":"108228","DOI":"10.1016\/j.pharmthera.2022.108228","volume":"237","author":"E Genetzakis","year":"2022","unstructured":"Genetzakis E, Gilchrist J, Kassiou M, Figtree GA (2022) Development and clinical translation of P2X7 receptor antagonists: a potential therapeutic target in coronary artery disease? Pharmacol Ther 237:108228","journal-title":"Pharmacol Ther"},{"key":"10190_CR15","doi-asserted-by":"publisher","first-page":"A2082","DOI":"10.1161\/atvb.44.suppl_1.2082","volume":"44","author":"S Geng","year":"2024","unstructured":"Geng S, Li L (2024) Neutrophil programming in atherosclerosis. Arterioscler Thromb Vasc Biol 44:A2082\u2013A2082","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10190_CR16","doi-asserted-by":"publisher","first-page":"e37491","DOI":"10.1371\/journal.pone.0037491","volume":"7","author":"O Gidl\u00f6f","year":"2012","unstructured":"Gidl\u00f6f O, Smith JG, Melander O, L\u00f6vkvist H, Hedblad B, Engstr\u00f6m G, Nilsson P, Carlson J, Berglund G, Olsson S (2012) A common missense variant in the ATP receptor P2X7 is associated with reduced risk of cardiovascular events. PLoS ONE 7:e37491","journal-title":"PLoS ONE"},{"key":"10190_CR17","doi-asserted-by":"publisher","first-page":"15381","DOI":"10.3390\/ijms232315381","volume":"23","author":"FR Guerini","year":"2022","unstructured":"Guerini FR, Agliardi C, Bolognesi E, Zanzottera M, Caputo D, Pasanisi MB, Rovaris M, Clerici M (2022) Two single nucleotide polymorphisms in the purinergic receptor P2X7 gene are associated with disease severity in multiple sclerosis. Int J Mol Sci 23:15381","journal-title":"Int J Mol Sci"},{"key":"10190_CR18","doi-asserted-by":"publisher","first-page":"1352789","DOI":"10.3389\/fimmu.2024.1352789","volume":"15","author":"J Guggemos","year":"2024","unstructured":"Guggemos J, Fuller SJ, Skarratt KK, Mayer B, Schneider EM (2024) Loss-of-function\/gain-of-function polymorphisms of the ATP sensitive P2X7R influence sepsis, septic shock, pneumonia, and survival outcomes. Front Immunol 15:1352789","journal-title":"Front Immunol"},{"key":"10190_CR19","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1016\/j.atherosclerosis.2023.06.831","volume":"379","author":"S Ibrahim","year":"2023","unstructured":"Ibrahim S, De Goeij J, Reeskamp L, Planken RN, Hovingh GK, Min J, Earls J, Knaapen P, Wiegman A, Stroes E (2023) Lifetime exposure to high LDL cholesterol in familial hypercholesterolemia causes coronary atherosclerosis in young adults: the cheetah trial. Atherosclerosis 379:S54","journal-title":"Atherosclerosis"},{"key":"10190_CR20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3389\/fcvm.2019.00132","volume":"6","author":"H Lebas","year":"2019","unstructured":"Lebas H, Yahiaoui K, Martos R, Boulaftali Y (2019) Platelets are at the nexus of vascular diseases. Front Cardiovasc Med 6:132","journal-title":"Front Cardiovasc Med"},{"key":"10190_CR21","doi-asserted-by":"publisher","first-page":"e0221547","DOI":"10.1371\/journal.pone.0221547","volume":"14","author":"B Li","year":"2019","unstructured":"Li B, Lu X, Moeini M, Sakad\u017ei\u0107 S, Thorin E, Lesage F (2019) Atherosclerosis is associated with a decrease in cerebral microvascular blood flow and tissue oxygenation. PLoS ONE 14:e0221547","journal-title":"PLoS ONE"},{"key":"10190_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0106-z","author":"P Libby","year":"2019","unstructured":"Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, Tokg\u00f6zo\u011flu L, Lewis EF (2019) Atherosclerosis. Nat Rev Dis Primers. https:\/\/doi.org\/10.1038\/s41572-019-0106-z","journal-title":"Nat Rev Dis Primers"},{"key":"10190_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/GME.0000000000000991","volume":"25","author":"X Liu","year":"2018","unstructured":"Liu X, Rao S, Gong C, Li T, Ding L, Wang S, Zhong P, Wang J, Zhao J, Zhou Y (2018) Purinergic P2X7 receptor functional genetic polymorphisms are associated with the susceptibility to obesity in Chinese postmenopausal women. Menopause 25:329\u2013335","journal-title":"Menopause"},{"key":"10190_CR24","first-page":"729","volume":"118","author":"BS Marin","year":"2022","unstructured":"Marin BS, Cesena F, Laurinavicius AG, Santos RD, Bittencourt MS (2022) Raz\u00e3o Neutr\u00f3filo-Linf\u00f3cito e Aterosclerose da Aorta Abdominal entre Indiv\u00edduos Assintom\u00e1ticos. Arq Bras Cardiol 118:729\u2013734","journal-title":"Arq Bras Cardiol"},{"key":"10190_CR25","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.3390\/microorganisms11102508","volume":"11","author":"CA Naranjo-Galvis","year":"2023","unstructured":"Naranjo-Galvis CA, McLeod R, G\u00f3mez-Mar\u00edn JE, De-La-Torre A, Rocha-Roa C, Cardona N, Sep\u00falveda-Arias JC (2023) Genetic variations in the purinergic P2X7 receptor are associated with the immune response to ocular toxoplasmosis in Colombia. Microorganisms 11:2508","journal-title":"Microorganisms"},{"key":"10190_CR26","first-page":"1","volume":"8","author":"AV Poznyak","year":"2024","unstructured":"Poznyak AV, Orekhova VA, Sukhorukov VN, Melnichenko AA, Pleshko EM, Orekhov AN (2024) Platelet implication in atherosclerosis pathogenesis. Integr Biomed Res 8:1\u20138","journal-title":"Integr Biomed Res"},{"key":"10190_CR27","doi-asserted-by":"publisher","first-page":"8964587","DOI":"10.1155\/2017\/8964587","volume":"2017","author":"VV Revin","year":"2017","unstructured":"Revin VV, Ushakova AA, Gromova NV, Balykova LA, Revina ES, Stolyarova VV, Stolbova TA, Solomadin IN, Tychkov AY, Revina NV (2017) Study of Erythrocyte Indices, Erythrocyte Morphometric Indicators, and Oxygen-Binding Properties of Hemoglobin Hematoporphyrin Patients with Cardiovascular Diseases. Adv Hematol 2017:8964587","journal-title":"Adv Hematol"},{"key":"10190_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.5603\/CJ.a2020.0074","volume":"28","author":"X-X Shi","year":"2021","unstructured":"Shi X-X, Zheng K-C, Shan P-R, Zhang L, Wu S-J, Huang Z-Q (2021) Elevated circulating level of P2X7 receptor is related to severity of coronary artery stenosis and prognosis of acute myocardial infarction. Cardiol J 28:453\u2013459","journal-title":"Cardiol J"},{"key":"10190_CR29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1161\/ATVBAHA.120.315116","volume":"41","author":"BG Shokoples","year":"2021","unstructured":"Shokoples BG, Paradis P, Schiffrin EL (2021) P2X7 receptors: an untapped target for the management of cardiovascular disease. Arterioscler Thromb Vasc Biol 41:186\u2013199","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10190_CR30","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1096\/fj.09-150862","volume":"24","author":"L Stokes","year":"2010","unstructured":"Stokes L, Fuller SJ, Sluyter R, Skarratt KK, Gu BJ, Wiley JS (2010) Two haplotypes of the P2X7 receptor containing the Ala\u2010348 to Thr polymorphism exhibit a gain\u2010of\u2010function effect and enhanced interleukin\u20101\u03b2 secretion. FASEB J 24:2916\u20132927","journal-title":"FASEB J"},{"key":"10190_CR31","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/medicina55060298","volume":"55","author":"M Taheri","year":"2019","unstructured":"Taheri M, Sarani H, Moazeni-Roodi A, Naderi M, Hashemi M (2019) Association between P2X7 polymorphisms and susceptibility to tuberculosis: an updated meta-analysis of case-control studies. Medicina (B Aires) 55:298","journal-title":"Medicina (B Aires)"},{"key":"10190_CR32","doi-asserted-by":"publisher","first-page":"20190732","DOI":"10.1098\/rsif.2019.0732","volume":"17","author":"J Tarbell","year":"2020","unstructured":"Tarbell J, Mahmoud M, Corti A, Cardoso L, Caro C (2020) The role of oxygen transport in atherosclerosis and vascular disease. J R Soc Interface 17:20190732","journal-title":"J R Soc Interface"},{"key":"10190_CR33","first-page":"81","volume-title":"Trent RJBT-MM","author":"RJ Trent","year":"2012","unstructured":"Trent RJ (2012) Chapter 3 - DNA Genetic Testing. In: Fourth E (ed) Trent RJBT-MM. Academic Press, Boston\/Waltham, pp 81\u2013115"},{"key":"10190_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11302-016-9495-6","volume":"12","author":"I Varley","year":"2016","unstructured":"Varley I, Greeves JP, Sale C, Friedman E, Moran DS, Yanovich R, Wilson PJ, Gartland A, Hughes DC, Stellingwerff T (2016) Functional polymorphisms in the P2X7 receptor gene are associated with stress fracture injury. Purinergic Signal 12:103\u2013113","journal-title":"Purinergic Signal"},{"key":"10190_CR35","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00198-012-2059-x","volume":"24","author":"A Wesselius","year":"2013","unstructured":"Wesselius A, Bours MJL, Henriksen Z, Syberg S, Petersen S, Schwarz P, J\u00f8rgensen NR, Van Helden S, Dagnelie PC (2013) Association of P2X7 receptor polymorphisms with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients. Osteoporos Int 24:1235\u20131246","journal-title":"Osteoporos Int"},{"key":"10190_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11302-017-9566-3","volume":"13","author":"H Xu","year":"2017","unstructured":"Xu H, Gong C, He L, Rao S, Liu X, Nie Y, Liu C, Li T, Ding L, Tu Y (2017) Purinergic P2X7 receptor functional genetic polymorphisms are associated with the susceptibility to osteoporosis in Chinese postmenopausal women. Purinergic Signal 13:339\u2013346","journal-title":"Purinergic Signal"},{"key":"10190_CR37","doi-asserted-by":"publisher","first-page":"114509","DOI":"10.1016\/j.ab.2021.114509","volume":"642","author":"L Zhang","year":"2022","unstructured":"Zhang L, Liu D, Li B, Xie J, Liu J, Zhang Z (2022) Single nucleotide polymorphism genotyping of ALDH2 gene based on asymmetric PCR and fluorescent probe-mediated melting curves. Anal Biochem 642:114509","journal-title":"Anal Biochem"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10190-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-026-10190-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10190-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:06:25Z","timestamp":1790615185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-026-10190-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10190"],"URL":"https:\/\/doi.org\/10.1007\/s11302-026-10190-2","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"26 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol received approval from the Istinye University Human Research Ethics Committee (Protocol No: 23\u2013179).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"77"}}